Genomic assays provide a comprehensive view of the molecular mechanisms underlying toxicity. They help identify biomarkers that can be used for early detection of toxic effects, thereby improving risk assessment and safety evaluations. Additionally, genomic data can guide the development of therapeutic interventions by revealing potential targets for drug action or strategies to mitigate toxic effects.
